Associate Director, Global Market Access & Pricing
PTC Therapeutics, Inc.
Summary
The Associate Director, Global Market Access & Pricing will support the development and execution of global market access, reimbursement, and pricing strategies for inline and pipeline assets, with an emphasis on rare disease/orphan products. The role supports successful launches by enabling optimal pricing, sustainable patient access, and value maximization through close cross-functional partnership and enablement of regional and affiliate teams. The Associate Director will translate clinical and economic evidence into payer strategy and pricing recommendations and will develop global tools and materials that support local reimbursement submissions and price negotiations, aligned with overarching global approaches.
Job description
Job Description Summary
The Associate Director, Global Market Access & Pricing will support the development and execution of global market access, reimbursement, and pricing strategies for inline and pipeline assets, with an emphasis on rare disease/orphan products. The role supports successful launches by enabling optimal pricing, sustainable patient access, and value maximization through close cross-functional partnership and enablement of regional and affiliate teams. The Associate Director will translate clinical and economic evidence into payer strategy and pricing recommendations and will develop global tools and materials that support local reimbursement submissions and price negotiations, aligned with overarching global approaches.
The Associate Director, Global Market Access, is accountable for adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs) as appropriate.
Responsibilities
- Develop and execute global pricing and market access strategies for assigned assets in partnership with Commercial, Medical, HEOR, and Regulatory.
- Lead payer/HTA landscape assessments and targeted payer research to shape the value proposition, define evidence needs, and inform clinical development and evidence plans.
- Create and deliver core global access and pricing deliverables, including Global Value Dossiers (GVDs), negotiation strategy guidance, pricing recommendations, and affiliate training/enablement materials.
- Support HTA submissions/dossiers and reimbursement negotiations, and monitor evolving policy changes, competitor activity, and pricing/access dynamics to inform strategy updates.
- Perform pricing analytics across gross-to-net drivers, contracting/discounting assumptions, price corridors, and international reference pricing (IRP) impacts.
- Manage external vendors/consultants and budget as needed to deliver access and pricing workstreams.
- Partner with regional and local Market Access leads and HEOR in support of regional and local access needs, and assessment of product coverage and reimbursement gaps.
- Provides global market access recommendations into late-stage product development and the Global commercialization of new products.
- Management of assigned budget in alignment with department budget guidance.
- Performs other tasks and assignments as needed and specified by management.
Qualifications
Master’s degree in life sciences, pharmacy, health economics, business, or a related scientific discipline required (MSc, MPH, PhD, or equivalent advanced degree), with a minimum of 6 years of progressively responsible experience in Market Access, Pricing, Health Economics and Outcomes Research (HEOR), or related roles within the pharmaceutical, biotechnology, or related industry, including at least 5 years in global commercial organizations. Experience in rare disease/orphan products and related consulting is preferred.
- Experience developing value dossiers and supporting launch and lifecycle planning in a cross-functional environment.
- Excellent analytical, communication, and project management skills. Guiding cross-functional matrix teams to drive the global market access development and execution.
- Strong understanding of orphan drug pricing and Global payor processes.
- Knowledge of and hands-on experience in health outcomes and pricing.
- Demonstrated ability to lead the development of global value proposition and value dossier for orphan/specialty indications.
- Knowledge of international health care systems and pricing and reimbursement requirements.
- Demonstrated understanding of the dynamics of international health care systems and financing mechanisms.
- Demonstrated ability to collaborate in a fast-paced, matrixed, team environment consisting of internal and external team members.
- Demonstrated experience working and supervising external vendors.
- Experience in pharmaceutical product development, pricing and/or commercialization (may be concurrent with technical health outcomes and economics strategy experience).
- Proficiency with Microsoft Office.
- Excellent verbal and written communication and skills.
- Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines.
- Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects.
- Fluent in English (verbal and written).
Special knowledge or skills and/or licenses or certificates preferred
- Advanced degree (PhD, Master’s, MBA).
- Experience supporting the commercialization of an orphan, rare disease.
- Experience contributing to late-stage product development and the global commercialization of new products.
Travel requirements: Up to 20% (Domestic and International)
Requirements
- Master’s degree in life sciences, pharmacy, health economics, business, or a related scientific discipline required (MSc, MPH, PhD, or equivalent advanced degree)
- Minimum of 6 years of progressively responsible experience in Market Access, Pricing, HEOR, or related roles within the pharmaceutical, biotechnology, or related industry
- At least 5 years in global commercial organizations
- Experience developing value dossiers and supporting launch and lifecycle planning in a cross-functional environment
- Excellent analytical, communication, and project management skills
- Guiding cross-functional matrix teams to drive the global market access development and execution
- Strong understanding of orphan drug pricing and Global payor processes
- Knowledge of and hands-on experience in health outcomes and pricing
- Demonstrated ability to lead the development of global value proposition and value dossier for orphan/specialty indications
- Knowledge of international health care systems and pricing and reimbursement requirements
- Demonstrated understanding of the dynamics of international health care systems and financing mechanisms
- Demonstrated ability to collaborate in a fast-paced, matrixed, team environment consisting of internal and external team members
- Demonstrated experience working and supervising external vendors
- Experience in pharmaceutical product development, pricing and/or commercialization
- Proficiency with Microsoft Office
- Excellent verbal and written communication and skills
- Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines
- Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects
- Fluent in English (verbal and written)
- Experience in rare disease/orphan products and related consulting is preferred
- Advanced degree (PhD, Master’s, MBA) preferred
- Experience supporting the commercialization of an orphan, rare disease preferred
- Experience contributing to late-stage product development and the global commercialization of new products preferred
Benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Retirement savings plans
- Short-term incentives
- Long-term incentives
Company overview
PTC Therapeutics, Inc. is a patient-centered biopharmaceutical company founded in 1998 and headquartered in Warren, New Jersey. The company specializes in discovering, developing, and commercializing innovative medicines for children and adults living with rare and serious diseases. PTC focuses on orally administered small molecule drugs and gene therapies that regulate gene expression by targeting post-transcriptional control mechanisms. The company's therapeutic areas include orphan and ultra-orphan disorders, oncology, and anti-infectives, with a particular emphasis on genetic disorders affecting metabolism and neurology. PTC's commercialized products include treatments for Duchenne muscular dystrophy, aromatic L-amino acid decarboxylase deficiency, spinal muscular atrophy, and other rare conditions. The company operates globally with a dedicated team of approximately 939 employees and maintains a robust pipeline of investigational therapies. PTC is publicly traded on NASDAQ under the symbol PTCT and has established itself as a leader in rare disease therapeutics through its commitment to scientific innovation and patient-focused approach.